Femoral Head Avascular Necrosis in Heterozygous Sickle Haemoglobin, the Role of Parenteral Drug Abuse: A Case Report
Authors
Abstract:
Sickle cell trait is a benign haemoglobin disorder which rarely results in disease or complications. A few cases of osteonecrosis have been reported in the literature in parts of the world with advanced health care system. There are various predispositions to developing avascular necrosis in general, while the sickle beta globin gene inheritance is the most efficient factor. Injection drug abuse has not been strongly link to the development of bone necrosis. Here we report a case of bone necrosis in an elderly man and raise awareness on osteonecrosis being a possible complication of injection drug misuse in heterozygous sickle haemoglobin disorder. A 68 year old retired health dispensary attendant presented at the clinic with an 18 months history of progressive right hip pain associated with difficulty in walking. He had engaged in self prescriptions, procurements and repeated administrations of pentazocine injection into his anterior thighs. He had an abnormal gait with bilateral discharging ulcers on both thighs anteriorly. Haemoglobin protein electrophoresis revealed AS status, while the pelvic X-ray showed necrosis of the right femoral head. Consequently, osteonecrosis may be one of the ultimate complications of parenteral drug abuse in heterozygous sickle haemoglobinopathy.
similar resources
Avascular Necrosis of the Femoral Head: Are Any Genes Involved?
Avascular necrosis of the femoral head (ANFH) is a pathologic process that results from interruption of blood supply to the femur bone resulting in the death of bone cells and collapse of the femoral head. Nontraumatic ANFH continuesto be a significant challenge to orthopedic surgeons. While the exact mechanisms remain elusive, many new insights have emerged from research in the last decade tha...
full textAvascular necrosis of the femoral head.
The patient was a 51-year-old man who was evaluated by a physical therapist for a chief complaint of right hip pain. The patient was treated with a single bout of nonthrust hip joint mobilizations, but due to the patient's atypical response and long-term use of oral corticosteroid medications, he was referred to his primary care physician. Radiographs and subsequent magnetic resonance imaging r...
full textAvascular Necrosis of the Femoral Head
Since the recent publication of studies of the vascular pattern of the proximal femoral epiphysis in man by Tucker (1949), Trueta and Harrison (1953), Judet, Judet, Lagrange and Dunoyer (1955), and Trueta (1957) there has been a renewed interest in the mechanism of capital necrosis after fractures of the femoral neck. The literature on the subject is so extensive that no effort will be made her...
full textCore Decompression Surgery for Avascular Necrosis Can Delay Femoral Head Collapse in Patients with Sickle Cell Disease: A Case Report
Introduction Avascular necrosis (AVN) of the femoral head is a common orthopaedic complication in patients with sickle cell disease (SCD). By age 35, approximately half of patients homozygous for the sickle cell gene mutation have AVN, with involvement of both hips in 40-91% of patients. Without early intervention, the rate of femoral head collapse is high and often necessitates total hip arthr...
full textEarly avascular necrosis of the femoral head. Report of a case and review of the literature.
The clinical and pathological findings in a case of early avascular necrosis of the femoral head following renal transplantation are described. Regions of subchondral bone distant from the principal lesions showed increased numbers of empty osteocytic lacunae. This has been quantified and it is suggested that a loss of osteocytes is perhaps one of the earliest lesions leading to established ava...
full textefficacy of core decompression of femoral head to treat avascular necrosis in intravenous drug users.
core decompression (cd) of the femoral head is one of the effective treatments of avascular necrosis (avn), especially in the early stages of the disease. to investigate further the value of cd in treating the avn, this study was performed on patients with symptomatic avn with different etiologies who were treated with cd. this study was carried out on 25 patients (with the total number of 37 f...
full textMy Resources
Journal title
volume 3 issue 1
pages 40- 43
publication date 2017-01
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023